(Press-News.org) PLYMOUTH MEETING, PA [October 5, 2023] — The National Comprehensive Cancer Network® (NCCN®)—a non-profit alliance of leading cancer centers across the United States—has released a follow-up survey on the ongoing chemotherapy shortages: 72% of the centers surveyed continue to experience a shortage of carboplatin and 59% are still seeing a shortage of cisplatin. Overall, 86% of centers surveyed reported experiencing a shortage of at least one type of anti-cancer drug.
View the updated survey results at NCCN.org/platinum-update.
The NCCN Best Practices Committee originally shared survey results in June 2023, which found that 93% of cancer centers surveyed at that time were experiencing a shortage of carboplatin and 70% lacked a steady supply of cisplatin. NCCN’s follow-up survey was conducted September 6 – 20, 2023.
Both surveys focused on two platinum-based generic chemotherapy medications that are recommended for treating hundreds of different cancer scenarios according to the NCCN Drugs & Biologics Compendium (NCCN Compendium®). The searchable database features every recommended use for cancer medication found in any of the evidence-based, expert consensus recommendations in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)—the recognized standard for clinical direction and policy in cancer management.
“Everyone with cancer should have access to the best possible treatment according to the latest evidence and expert consensus guidelines,” said Robert W. Carlson, MD, Chief Executive Officer for NCCN. “Drug shortages aren’t new, but the widespread impact makes this one particularly alarming. It is extremely concerning that this situation continues despite significant attention and effort over the past few months. We need enduring solutions in order to safeguard people with cancer and address any disparities in care.”
The September 2023 survey included responses from 29 out of NCCN’s 33 Member Institutions—all leading academic centers from across the United States, which may not reflect any additional challenges experienced by smaller community practices serving rural and marginalized patients. Nearly all reported being able to continue treating every patient who needs carboplatin or cisplatin, despite lowered supply, primarily by implementing strict waste management strategies.
The survey results also revealed several other key medications that are currently in short supply, including 66% reporting a shortage of methotrexate, 55% for 5-flourouracil, 45% for fludarabine, and 41% for hydrocortisone.
“These drug shortages are the result of decades of systemic challenges,” said Alyssa Schatz, MSW, Senior Director of Policy and Advocacy for NCCN. “We recognize that comprehensive solutions take time and we appreciate everyone who has put forth proposals to improve investment in generics and our data infrastructure. At the same time, we have to acknowledge that the cancer drug shortage has been ongoing for months, which is unacceptable for anyone impacted by cancer today. These new survey results remind us that we are still in an ongoing crisis and must respond with appropriate urgency.”
NCCN Continues to Advocate for Solutions
NCCN released a statement on the shortage in June 2023, calling for action from the Federal Government and its agencies, the pharmaceutical industry, providers, and payers to work together to ensure quality, effective, equitable, and accessible cancer care. Since then, the organization has worked with the White House, National Cancer Institute, Centers for Medicaid and Medicare, along with other oncology nonprofits to advocate for short- and long-term fixes.
“We are grateful for all of the progress that has been made since June, but we won’t rest until we know we can prevent anti-cancer drug shortages from happening in the future,” said Dr. Carlson.
View an overview of NCCN’s findings to date on drug cancer shortages at NCCN.org/policy.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
NEW YORK, NY and SANTA BARBARA, CA – The American Federation for Aging Research (AFAR) and the Glenn Foundation for Medical Research are pleased to announce the 2023 Glenn Foundation for Medical Research and AFAR Research Grants for Junior Faculty recipients.
The Research Grant for Junior Faculty provides an early career investigator with up to $150,000 for one to two ...
Pireco Co., Ltd., a student-led venture company of UNIST, has accomplished a remarkable feat in establishing an international standard for their multi-biometrics identification solution designed for companion animals. This groundbreaking solution simplifies the process of accurately identifying and registering companion animals by simply scanning the distinctive patterns of ridges and creases on their noses using smartphones. The advent of this pioneering technology sets the stage for global registration ...
Researchers from Concordia University and Northwestern University published a new Journal of Marketing study that presents the Comparative Method of Valuation as a more accurate way to measure customers’ willingness to pay for a product or service.
The study, forthcoming in the Journal of Marketing, is titled “Measuring Willingness to Pay: A Comparative Method of Valuation” and is authored by Sharlene He, Eric T. Anderson, and Derek D. Rucker.
At the grocery store, a customer may be willing to pay $18 for a bottle of Riesling when comparing it to a $15 bottle ...
The Alliance for Clinical Trials in Oncology today announced that the Alliance Data and Safety Monitoring Board (DSMB) determined that the phase III AMBASSADOR (A031501) trial met one of its dual primary endpoints of disease-free survival (DFS) for the adjuvant treatment of patients with localized muscle-invasive urothelial carcinoma (MIUC) and locally advanced urothelial carcinoma. At a pre-specified interim analysis review, pembrolizumab demonstrated a statistically significant and clinically meaningful ...
One treatment each of two psychedelic drugs lowered depression and anxiety and improved cognitive functioning in a sample of U.S. special operations forces veterans who sought care at a clinic in Mexico, according to a new analysis of the participants’ charts.
The treatment included a combination of ibogaine hydrochloride, derived from the West African shrub iboga, and 5-MeO-DMT, a psychedelic substance secreted by the Colorado River toad. Both are designated as Schedule I drugs under the U.S. Controlled Substances Act.
In addition to relieving symptoms of post-traumatic stress disorder (PTSD), ...
HOUSTON – (Oct. 5, 2023) – An interdisciplinary team of Rice University scientists has won a $1.9 million National Science Foundation grant for research on materials that could serve as the basis for next-generation energy-efficient computing devices.
The team ⎯ led by Kaiyuan Yang and including co-investigators Ramamoorthy Ramesh, Yimo Han, Douglas Natelson, Shengxi Huang and Lane Martin ⎯ will focus on multiferroics, materials with distinctive electric and magnetic properties that carry “transformative technological potential,” ...
AMES, Iowa – The foundation of a house remains, the basement ripped open and exposed, with the rest of the house blown away. A brick-veneered bank building partially caved in. A collapsed high school gym. Gravestones knocked over. Debris piercing a building.
Partha Sarkar kept hitting next, scrolling through the photo evidence of the destruction he gathered and assessed the day after an EF5 tornado ripped through Parkersburg on May 25, 2008.
Then Sarkar, professor and interim chair of aerospace engineering at Iowa State University, opened a photo showing a house ...
Acoels have been found to host a wide diversity of symbiotic, photosynthetic microalgae.
Animals and plants need energy. Some animals get energy by eating other animals, and many plants harvest the energy in sunlight through photosynthesis. However, in the ocean, there exists a remarkable group of small, worm-like animals called acoels that do both—some acoels form relationships (symbiosis) with single-celled, photosynthetic microalgae.
A study by Assistant Professor Kevin Wakeman and his undergraduate student, Siratee Riewluang, at Hokkaido University, Japan, has shed some light on the biodiversity underpinning symbiotic relationships between acoels and microalgae. ...
Bumblebees have a remarkably successful method for fighting off Asian hornets, new research shows.
When attacked, buff-tailed bumblebees drop to the ground – taking the hornets down with them. This either causes the hornet to lose its grip, or the bee raises its sting and tussles until the hornet gives up.
University of Exeter scientists witnessed over 120 such attacks, and were stunned to find that bumblebees fought off the hornets every time.
Despite this, they found bumblebee colonies had reduced growth rates in ...
The American Association for the Advancement of Science (AAAS) has conceived of and launched a new artificial intelligence (AI) fellowship in just two months — record speed — to support leaders in Congress as they craft legislation, in particular policies related to emerging opportunities and challenges with AI. Capitol Hill’s surging interest in AI policy follows the public release of ChatGPT and other generative AI tools.
The STPF Rapid Response Cohort in AI operates under the AAAS Science & Technology Policy Fellowships (STPF) program and is part of the 51st class of 276 scientists and engineers placed across ...
